MAPT and tauopathy: While studies of non-gyrencephalic animal brains cannot produce the CTE lesion, a 2015 TBI mouse model produced p-tau immediately after a TBI, followed by later production of pathological tau deposits in the brain, while antibody-blocking of p-tau prevented tauopathy development.